PHGDH inhibition promotes multi-lineage differentiation of embryonal carcinoma stem cells via ubiquitination and proteasomal degradation of Oct4 and positively regulating the stability of the differentiation marker β3-tubulin. The gene discussed is POU5F1; the disease is embryonal carcinoma.